Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SAVE: Glucosamine + Meloxicam vs Glucosamine + Chondroitin in Knee OA
NCT03936192Phase 3Withdrawn
- Sponsor
- Eurofarma
- Start
- Jan 2019
- Primary completion
- Feb 2021
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of meloxicam in knee osteoarthritis (OA), sponsored by Eurofarma. Planned start Jan 2019; status: withdrawn.
02
Drugs
meloxicam
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on NCT03936192.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03936192.